OTCMKTS:CURLFCuraleaf Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Curaleaf Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $6.01 +0.05 (+0.84 %) (As of 05/22/2020 04:00 PM ET) Add Compare Share Today's Range$5.86Now: $6.01▼$6.2550-Day Range$3.56MA: $4.42▼$6.5852-Week Range$2.54Now: $6.01▼$9.66Volume497,185 shsAverage Volume552,689 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlinesSocial Media Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles. The company also provides non-cannabis services to licensed cannabis operators in the areas of cultivation, extraction and production, and retail operations. As of March 21, 2019, it operated 43 dispensaries, 12 cultivation sites, and 11 processing sites. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.Read More Beat the Market (BTM) Rank™ 3.4 Analyst's Opinion Consensus RatingCuraleaf has received a consensus rating of Buy. The company's average rating score is 2.71, and is based on 5 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.72, Curaleaf has a potential upside of 61.8% from its current price of $6.01.Amount of Analyst CoverageCuraleaf has only been the subject of 3 research reports in the past 90 days. Previous Next 3.4 Community Rank Outperform VotesCuraleaf has received 81 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCuraleaf has received 39 “underperform” votes. (Add your “underperform” vote.)Community SentimentCuraleaf has received 67.50% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Curaleaf and other stocks. Vote “Outperform” if you believe CURLF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CURLF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCuraleaf does not currently pay a dividend.Dividend GrowthCuraleaf does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Curaleaf insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.4Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.35 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CURLF Previous Symbol CUSIPN/A CIKN/A Webwww.curaleaf.com Phone781-451-0150Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:CURLF Rates by TradingView Receive CURLF News and Ratings via Email Sign-up to receive the latest news and ratings for CURLF and its competitors with MarketBeat's FREE daily newsletter. Curaleaf (OTCMKTS:CURLF) Frequently Asked Questions How has Curaleaf's stock been impacted by COVID-19 (Coronavirus)? Curaleaf's stock was trading at $4.42 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CURLF shares have increased by 35.9% and is now trading at $6.0086. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Curaleaf? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Curaleaf. What price target have analysts set for CURLF? 7 brokers have issued 12 month price objectives for Curaleaf's shares. Their forecasts range from $5.00 to $15.00. On average, they expect Curaleaf's stock price to reach $9.72 in the next twelve months. This suggests a possible upside of 61.8% from the stock's current price. View analysts' price targets for Curaleaf. Has Curaleaf been receiving favorable news coverage? Media headlines about CURLF stock have been trending somewhat negative on Sunday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Curaleaf earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutCuraleaf. Who are some of Curaleaf's key competitors? Some companies that are related to Curaleaf include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). View all competitors. Who are Curaleaf's key executives? Curaleaf's management team includes the following people: Mr. Boris Alexis Jordan, Exec. Chairman (Age 53)Mr. Joseph Lusardi, Pres, CEO & Director (Age 44)Mr. Neil P. Davidson, Chief Financial Officer (Age 47)Mr. Stuart Anthony Wilcox, Chief Operating Officer (Age 58)Ms. Christine Rigby, Sr. VP of Investor Relations What is Curaleaf's stock symbol? Curaleaf trades on the OTCMKTS under the ticker symbol "CURLF." How do I buy shares of Curaleaf? Shares of CURLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Curaleaf's stock price today? One share of CURLF stock can currently be purchased for approximately $6.01. What is Curaleaf's official website? The official website for Curaleaf is www.curaleaf.com. How can I contact Curaleaf? The company can be reached via phone at 781-451-0150. This page was last updated on 5/24/2020 by MarketBeat.com Staff
